Works by Cervera, Marta


Results: 36
    1
    2
    3
    4
    5
    6
    7

    Survival improvement of patients with FLT3 mutated acute myeloid leukemia: results from a prospective 9 years cohort.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00839-1
    By:
    • Oñate, Guadalupe;
    • Pratcorona, Marta;
    • Garrido, Ana;
    • Artigas-Baleri, Alicia;
    • Bataller, Alex;
    • Tormo, Mar;
    • Arnan, Montserrat;
    • Vives, Susana;
    • Coll, Rosa;
    • Salamero, Olga;
    • Vall-Llovera, Ferran;
    • Sampol, Antònia;
    • Garcia, Antoni;
    • Cervera, Marta;
    • Avila, Sara Garcia;
    • Bargay, Joan;
    • Ortín, Xavier;
    • Nomdedéu, Josep F.;
    • Esteve, Jordi;
    • Sierra, Jorge
    Publication type:
    Article
    8

    Survival improvement of patients with FLT3 mutated acute myeloid leukemia: results from a prospective 9 years cohort.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00839-1
    By:
    • Oñate, Guadalupe;
    • Pratcorona, Marta;
    • Garrido, Ana;
    • Artigas-Baleri, Alicia;
    • Bataller, Alex;
    • Tormo, Mar;
    • Arnan, Montserrat;
    • Vives, Susana;
    • Coll, Rosa;
    • Salamero, Olga;
    • Vall-Llovera, Ferran;
    • Sampol, Antònia;
    • Garcia, Antoni;
    • Cervera, Marta;
    • Avila, Sara Garcia;
    • Bargay, Joan;
    • Ortín, Xavier;
    • Nomdedéu, Josep F.;
    • Esteve, Jordi;
    • Sierra, Jorge
    Publication type:
    Article
    9

    A novel targeted RNA-Seq panel identifies a subset of adult patients with acute lymphoblastic leukemia with BCR-ABL1-like characteristics.

    Published in:
    Blood Cancer Journal, 2020, v. 10, n. 4, p. 1, doi. 10.1038/s41408-020-0308-3
    By:
    • Sánchez, Ricardo;
    • Ribera, Jordi;
    • Morgades, Mireia;
    • Ayala, Rosa;
    • Onecha, Esther;
    • Ruiz-Heredia, Yanira;
    • Juárez-Rufián, Alexandra;
    • de Nicolás, Rodrigo;
    • Sánchez-Pina, José;
    • Vives, Susana;
    • Zamora, Lurdes;
    • Mercadal, Santiago;
    • Coll, Rosa;
    • Cervera, Marta;
    • García, Olga;
    • Ribera, Josep-Maria;
    • Martínez-López, Joaquín
    Publication type:
    Article
    10

    P1147: FEASIBILITY AND OUTCOME AFTER DOSE REDUCTION OF IMMUNOCHEMOTHERAPY IN YOUNG ADULTS WITH BURKITT LYMPHOMA AND LEUKEMIA. RESULTS OF THE BURKIMAB14 TRIAL.

    Published in:
    2023
    By:
    • Maria Ribera, Josep;
    • Morgades, Mireia;
    • García-Calduch, Olga;
    • Sirvent, Maialen;
    • Buendía Ureña, Buenaventura;
    • Cervera, Marta;
    • Luzardo, Hugo;
    • Hernández Rivas, Jesus;
    • Sitges Arriaga, Marta;
    • Garcia Cadenas, Irene;
    • Abrisquet Acosta, Pablo;
    • Montesinos, Pau;
    • Bastos Oreiro, Mariana;
    • Queipo de Llano, María-Paz;
    • Bravo, Pilar;
    • Torrent, Anna;
    • Puente, Maria Pilar Herrera;
    • Garcia-Guiñon, Antonio;
    • Vall-Llovera Calmet, Ferran;
    • Serrano, Josefina
    Publication type:
    Abstract
    11

    Impact of Center-related Characteristics and Macroeconomic Factors on the Outcome of Adult Patients With Acute Lymphoblastic Leukemia Treated With Pediatric-inspired Protocols.

    Published in:
    2023
    By:
    • Barba, Pere;
    • Morgades, Mireia;
    • Montesinos, Pau;
    • Gonzalez-Campos, Jose;
    • Torrent, Anna;
    • Gil, Cristina;
    • Bernal, Teresa;
    • Tormo, Mar;
    • Mercadal, Santiago;
    • Novoa, Sandra;
    • García-Cadenas, Irene;
    • de Llano, M. Paz Queipo;
    • Cervera, Marta;
    • Coll, Rosa;
    • Bermudez, Arancha;
    • Amigo, M. Luz;
    • Monsalvo, Silvia;
    • Esteve, Jordi;
    • Garcia-Boyero, Raimundo;
    • Novo, Andres
    Publication type:
    Letter
    12
    13

    Frequency and prognostic significance of additional cytogenetic abnormalities to the Philadelphia chromosome in young and older adults with acute lymphoblastic leukemia.

    Published in:
    Leukemia & Lymphoma, 2018, v. 59, n. 1, p. 146, doi. 10.1080/10428194.2017.1326596
    By:
    • Motlló, Cristina;
    • Ribera, Josep-Maria;
    • Morgades, Mireia;
    • Granada, Isabel;
    • Montesinos, Pau;
    • Mercadal, Santiago;
    • González-Campos, José;
    • Moreno, María-José;
    • Barba, Pere;
    • Cervera, Marta;
    • Barrios, Manuel;
    • Novo, Andrés;
    • Bernal, Teresa;
    • Hernández-Rivas, Jesús-María;
    • Abella, Eugenia;
    • Amigo, María-Luz;
    • Tormo, Mar;
    • Martino, Rodrigo;
    • Lavilla, Esperanza;
    • Bergua, Juan
    Publication type:
    Article
    14

    Phenotypic Expression and Outcomes in Patients with the p.Arg301Gln GLA Variant in Anderson–Fabry Disease.

    Published in:
    International Journal of Molecular Sciences, 2024, v. 25, n. 8, p. 4299, doi. 10.3390/ijms25084299
    By:
    • Blanco, Rocío;
    • Rico-Ramírez, Yolanda;
    • Hermida-Ameijeiras, Álvaro;
    • Abdullah, Israa Mahmoud Sanad;
    • Lau, Kolja;
    • Alvarez-Rubio, Jorge;
    • Fortuny, Elena;
    • Martínez-Monzonís, Amparo;
    • Nowak, Albina;
    • Nordbeck, Peter;
    • Veras-Burgos, Carlos;
    • Pons-Llinares, Jaume;
    • Rossi, Emiliano;
    • Caimi-Martínez, Fiama;
    • Bosch-Rovira, Teresa;
    • Alamar-Cervera, Marta;
    • Ruiz-Pizarro, Virginia;
    • Torres-Juan, Laura;
    • Heine-Suñer, Damian;
    • Ripoll-Vera, Tomás
    Publication type:
    Article
    15
    16

    Real-world study in severe eosinophilic asthma patients refractory to anti-IL5 biological agents treated with benralizumab in Spain (ORBE study).

    Published in:
    2021
    By:
    • Martínez-Moragón, Eva;
    • García-Moguel, Ismael;
    • Nuevo, Javier;
    • Resler, Gustavo;
    • ORBE study investigators;
    • Antépara, Ignacio;
    • Arismendi-Núñez, Ebymar;
    • Casas-Maldonado, Francisco;
    • Dávila-González, Ignacio;
    • Velasco-Garrido, Jose Luis;
    • Díaz-Campos, Rocío;
    • Díaz-Donado, Carmen;
    • Gálvez, Beatriz;
    • Izquierdo, Jose Luis;
    • López-Viña, Antolín;
    • Navarro-Soriano, Cristina;
    • Palop-Cervera, Marta;
    • de Llano, Luis Pérez;
    • Plaza, Vicente;
    • Racionero-Casero, Miguel Ángel
    Publication type:
    journal article
    17
    18

    Incidence and outcome after first molecular versus overt recurrence in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia included in the ALL Ph08 trial from the Spanish PETHEMA Group.

    Published in:
    2019
    By:
    • Ribera, Josep‐Maria;
    • García, Olga;
    • Moreno, María‐José;
    • Barba, Pere;
    • García‐Cadenas, Irene;
    • Mercadal, Santiago;
    • Montesinos, Pau;
    • Barrios, Manuel;
    • González‐Campos, José;
    • Martínez‐Carballeira, Daniel;
    • Gil, Cristina;
    • Ribera, Jordi;
    • Vives, Susana;
    • Novo, Andrés;
    • Cervera, Marta;
    • Serrano, Josefina;
    • Lavilla, Esperanza;
    • Abella, Eugenia;
    • Tormo, Mar;
    • Amigo, María‐Luz
    Publication type:
    journal article
    19

    Sequential changes in urinary biomarker levels in patients with cirrhosis and severe hepatorenal syndrome.

    Published in:
    Liver International, 2021, v. 41, n. 11, p. 2729, doi. 10.1111/liv.15069
    By:
    • Solé, Cristina;
    • Ma, Ann T.;
    • Solà, Elsa;
    • Carol, Marta;
    • Fabrellas, Núria;
    • Juanola, Adrià;
    • Napoleone, Laura;
    • Gratacós‐Ginès, Jordi;
    • Bassegoda, Octavi;
    • Cervera, Marta;
    • Pérez, Martina;
    • Rubio, Ana Belén;
    • Avitabile, Emma;
    • Morales‐Ruiz, Manuel;
    • Graupera, Isabel;
    • Pose, Elisa;
    • Kamath, Patrick S.;
    • Ginès, Pere
    Publication type:
    Article
    20
    21

    Oxidative Stress, a Crossroad between Rare Diseases and Neurodegeneration.

    Published in:
    Antioxidants, 2020, v. 9, n. 4, p. 313, doi. 10.3390/antiox9040313
    By:
    • Espinós, Carmen;
    • Galindo, Máximo Ibo;
    • García-Gimeno, María Adelaida;
    • Ibáñez-Cabellos, José Santiago;
    • Martínez-Rubio, Dolores;
    • Millán, José María;
    • Rodrigo, Regina;
    • Sanz, Pascual;
    • Seco-Cervera, Marta;
    • Sevilla, Teresa;
    • Tapia, Andrea;
    • Pallardó, Federico V.
    Publication type:
    Article
    22
    23

    Salvage Therapy with Second-Generation Inhibitors for FLT3 Mutated Acute Myeloid Leukemia: A Real-World Study by the CETLAM and PETHEMA Groups.

    Published in:
    Cancers, 2024, v. 16, n. 23, p. 4028, doi. 10.3390/cancers16234028
    By:
    • Vives, Susana;
    • Quintela, David;
    • Morgades, Mireia;
    • Cano-Ferri, Isabel;
    • Serrano, Alfons;
    • Acuña-Cruz, Evelyn;
    • Cervera, Marta;
    • Díaz-Beyá, Marina;
    • Vidriales, Belén;
    • Raposo-Puglia, José Ángel;
    • Arnan, Montserrat;
    • Garrido, Ana;
    • Balerdi, Amaia;
    • Cabello, Ana Isabel;
    • Herrera-Puente, Pilar;
    • Serrano, Josefina;
    • Coll, Rosa;
    • Tormo, Mar;
    • López-Marín, Javier;
    • García-Ávila, Sara
    Publication type:
    Article
    24
    25

    Prognostic heterogeneity of adult B‐cell precursor acute lymphoblastic leukaemia patients with t(1;19)(q23;p13)/TCF3‐PBX1 treated with measurable residual disease‐oriented protocols.

    Published in:
    British Journal of Haematology, 2022, v. 196, n. 3, p. 670, doi. 10.1111/bjh.17844
    By:
    • Ribera, Jordi;
    • Granada, Isabel;
    • Morgades, Mireia;
    • González, Teresa;
    • Ciudad, Juana;
    • Such, Esperanza;
    • Calasanz, María‐José;
    • Mercadal, Santiago;
    • Coll, Rosa;
    • González‐Campos, José;
    • Tormo, Mar;
    • García‐Cadenas, Irene;
    • Gil, Cristina;
    • Cervera, Marta;
    • Barba, Pere;
    • Costa, Dolors;
    • Ayala, Rosa;
    • Bermúdez, Arancha;
    • Orfao, Alberto;
    • Ribera, Josep‐Maria
    Publication type:
    Article
    26

    Achieving clinical outcomes with benralizumab in severe eosinophilic asthma patients in a real-world setting: ORBE II study.

    Published in:
    Respiratory Research, 2023, v. 24, n. 1, p. 1, doi. 10.1186/s12931-023-02539-7
    By:
    • Padilla-Galo, Alicia;
    • Moya Carmona, Isabel;
    • Ausín, Pilar;
    • Carazo Fernández, Luis;
    • García-Moguel, Ismael;
    • Velasco-Garrido, José Luis;
    • Andújar-Espinosa, Rubén;
    • Casas-Maldonado, Francisco;
    • Martínez-Moragón, Eva;
    • Martínez Rivera, Carlos;
    • Vera Solsona, Elisabet;
    • Sánchez-Toril López, Fernando;
    • Trisán Alonso, Andrea;
    • Blanco Aparicio, Marina;
    • Valverde-Monge, Marcela;
    • Valencia Azcona, Borja;
    • Palop Cervera, Marta;
    • Nuevo, Javier;
    • Sánchez Tena, Jesús;
    • Resler, Gustavo
    Publication type:
    Article
    27

    Achieving clinical outcomes with benralizumab in severe eosinophilic asthma patients in a real-world setting: orbe II study.

    Published in:
    Respiratory Research, 2023, v. 24, n. 1, p. 1, doi. 10.1186/s12931-023-02539-7
    By:
    • Padilla-Galo, Alicia;
    • Moya Carmona, Isabel;
    • Ausín, Pilar;
    • Carazo Fernández, Luis;
    • García-Moguel, Ismael;
    • Velasco-Garrido, José Luis;
    • Andújar-Espinosa, Rubén;
    • Casas-Maldonado, Francisco;
    • Martínez-Moragón, Eva;
    • Martínez Rivera, Carlos;
    • Vera Solsona, Elisabet;
    • Sánchez-Toril López, Fernando;
    • Trisán Alonso, Andrea;
    • Blanco Aparicio, Marina;
    • Valverde-Monge, Marcela;
    • Valencia Azcona, Borja;
    • Palop Cervera, Marta;
    • Nuevo, Javier;
    • Sánchez Tena, Jesús;
    • Resler, Gustavo
    Publication type:
    Article
    28
    29
    30
    31

    Diverse real-life outcomes after intensive risk-adapted therapy for 1034 AML patients from the CETLAM Group.

    Published in:
    Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-024-01205-5
    By:
    • Oñate, Guadalupe;
    • Garrido, Ana;
    • Arnan, Montserrat;
    • Pomares, Helena;
    • Alonso, Ester;
    • Tormo, Mar;
    • Diaz-Beya, Marina;
    • Vives, Susana;
    • Zamora, Lurdes;
    • Sampol, Antonia;
    • Coll, Rosa;
    • Salamero, Olga;
    • Cervera, Marta;
    • Garcia, Antoni;
    • Vall-Llovera, Ferran;
    • Garcia-Avila, Sara;
    • Bargay, Joan;
    • Ortin, Xavier;
    • Iranzo, Eva;
    • Guijarro, Francisca
    Publication type:
    Article
    32
    33
    34

    Results of the compassionate program of inotuzumab ozogamicin for adult patients with relapsed or refractory acute lymphoblastic leukemia in Spain.

    Published in:
    European Journal of Haematology, 2023, v. 111, n. 3, p. 485, doi. 10.1111/ejh.14031
    By:
    • Torrent, Anna;
    • Morgades, Mireia;
    • García‐Calduch, Olga;
    • de Llano, María Paz Queipo;
    • Montesinos, Pau;
    • Navarro, Irene;
    • Hernández‐Rivas, Jesús María;
    • Bárez‐García, Abelardo;
    • González‐Campos, José;
    • Oiartzabal, Itziar;
    • Valero, Marta;
    • Cervera, Marta;
    • Zudaire, Teresa;
    • Albors‐Ferreiro, Manuel;
    • López‐Godino, Oriana;
    • Gil‐Cortés, Cristina;
    • Villalón, Lucía;
    • Saldaña, Raquel;
    • Ribera, Josep‐María
    Publication type:
    Article
    35
    36